FDA inspection
Morton Grove Pharmaceuticals, Inc.: FDA inspection ending Mar 8, 2002
FDA inspection 209158 · Voluntary Action Indicated (VAI) · Morton Grove, IL
Key facts
| Inspection ID | 209158 |
|---|---|
| Firm | Morton Grove Pharmaceuticals, Inc. |
| FEI number | 1420913 |
| Address | 6451 Main St |
| City | Morton Grove |
| State | IL |
| ZIP | 60053-2633 |
| Fiscal year | 2002 |
| Inspection end date | Mar 8, 2002 |
| Classification | Voluntary Action Indicated (VAI) |
| Project area | Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Generic Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|Generic Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|Generic Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|Generic Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|Generic Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|Generic Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|Generic Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|Generic Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|Generic Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|Generic Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|Generic Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|Generic Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|Generic Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|Generic Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|Generic Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|Generic Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|Generic Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|Generic Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|Generic Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|Generic Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|Generic Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|Generic Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|Generic Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|Generic Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|Generic Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|Generic Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|Generic Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|Generic Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|Generic Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|Generic Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|Generic Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|Generic Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|Generic Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|Generic Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|Generic Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|Generic Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|Generic Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|Generic Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|Generic Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|Generic Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|Generic Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|Generic Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|Generic Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|Generic Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|Generic Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|Generic Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|Generic Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|Generic Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|Generic Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|Generic Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|Generic Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|Generic Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|Generic Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|Generic Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|Generic Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|Generic Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|Generic Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|Generic Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|Generic Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|Generic Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|Generic Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|Generic Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|Generic Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|Generic Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|Generic Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|Generic Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|Generic Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|Generic Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|Generic Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|Generic Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|Generic Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs |
| Product type | Drugs |
At a glance
- None Citations
- 1–9 Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- Yes Establishment inspection report (EIR) exists
- 10–99 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data